Quick Answer
Medicenna Therapeutics Corp. reported Total Assets of $36.45 million for fiscal year 2023.
Medicenna Therapeutics Corp. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2023 | $36.45M | +55.4% |
| 2022 | $23.46M | -44.5% |
| 2021 | $42.25M | — |
- Medicenna Therapeutics Corp. showed an increase of +55.4% in Total Assets compared to the prior fiscal year.
- Over the 2021–2023 period, Medicenna Therapeutics Corp.’s total assets has declined by 13.7% (from $42.25 million to $36.45 million).
- The most recent figure is from Medicenna Therapeutics Corp.’s fiscal year 2022 report (Form 20-F), filed with the SEC on June 27, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: